Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiPl

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Nature

• Publication date

  1997-09-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/38291PMID 9296497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection and analysis of living, growth-inhibited mammalian cells following transfection.

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• BRCA1 is a component of the RNA polymerase II holoenzyme.

  1997cited by this paper
• AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression

  1997cited by this paper
• Human BRCA1 inhibits growth in yeast: potential use in diagnostic testing.

  1997cited by this paper
• Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region

  1997cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997cited by this paper
• BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.

  1996cited by this paper
• Evidence for a transcriptional activation function of BRCA1 C-terminal region.

  1996cited by this paper
• Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• Location of BRCA1 in Human Breast and Ovarian Cancer Cells

  1996cited by this paper
• Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1995cited by this paper
• Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.

  1995cited by this paper
• p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

  1995cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation.

  1995cited by this paper
• Inhibitors of mammalian G1 cyclin-dependent kinases.

  1995cited by this paper
• Unusual case of Smith-Lemli-Opitz syndrome "type II".

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• WAF1, a potential mediator of p53 tumor suppression.

  1993cited by this paper
• Construction and identification of cDNA clones for mouse ribosomal proteins: application for the study of r-protein gene expression.

  1980cited by this paper

• Comprehensive Bioinformatics Analysis Reveals Associations between the DNA Damage Response and Osteoarthritis

  2025cites this paper
• CtBP: A mediator of a metabolic switch from homeostasis to carcinogenesis

  2025cites this paper
• Druggable Molecular Networks in BRCA1/BRCA2-Mutated Breast Cancer

  2025cites this paper
• Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview

  2025cites this paper
• A negative feedback loop underlies the Warburg effect

  2024influential citation
• Cathepsins and cancer risk: a Mendelian randomization study

  2024cites this paper
• A therapeutic algorithm guiding subsequent therapy selection after CDK4/6 inhibitors' failure: a review of current and investigational treatment for HR+/Her2- breast cancer.

  2024cites this paper
• BRCA1 heterozygosity promotes DNA damage-induced senescence in a sex-specific manner following repeated mild traumatic brain injury

  2023cites this paper
• CtBP: A global regulator of balancing acts and homeostases.

  2023cites this paper
• Beyond PARP Inhibitors in Advanced Breast Cancer Patients with Germline BRCA1/2 Mutations: Focus on CDK4/6-Inhibitors and Data Review on Other Biological Therapies

  2023cites this paper
• Keep Calm and Carry on with Extra Centrosomes

  2022cites this paper
• BRCA1 and DNA damage response

  2022cites this paper
• BRCA1: An Endocrine and Metabolic Regulator

  2022cites this paper
• Cyclin-Dependent Kinase 4/6 Inhibitor Outcomes in Patients With Advanced Breast Cancer Carrying Germline Pathogenic Variants in DNA Repair–Related Genes

  2022cites this paper
• Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA

  2022cites this paper
• DNA damage response and repair in the development and treatment of brain tumors.

  2022cites this paper
• Breast cancer type 1 and neurodegeneration: consequences of deficient DNA repair

  2021cites this paper
• Opposing effects of BRCA1 mRNA expression on patient survival in breast and colorectal cancer and variations among African American, Asian, and younger patients

  2021cites this paper
• Therapeutic targets of cancer drugs: Modulation by melatonin.

  2020cites this paper
• BRCA1 protects cardiac microvascular endothelial cells against irradiation by regulating p21-mediated cell cycle arrest.

  2020cites this paper
• Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma

  2020cites this paper
• Expression of tripartite motif-containing 44 and its prognostic and clinicopathological value in human malignancies:a meta-analysis

  2020cites this paper
• Transcriptional repression of p21 by EIF1AX promotes the proliferation of breast cancer cells

  2020cites this paper
• TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway

  2019cites this paper
• BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance

  2019cites this paper
• Polymorphism rs2395655 affects LEDGF/p75 binding activity and p21WAF1/CIP1 gene expression in esophageal squamous cell carcinoma

  2019cites this paper
• p21cip1/waf1 Coordinates Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress

  2019cites this paper
• Penfluridol: An antipsychotic agent suppresses lung cancer cell growth and metastasis by inducing G0/G1 arrest and apoptosis.

  2019cites this paper
• Ironing out the role of the cyclin‐dependent kinase inhibitor, p21 in cancer: Novel iron chelating agents to target p21 expression and activity

  2019cites this paper
• Lawrence Berkeley National Laboratory Recent Work Title Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure Permalink

  2019cites this paper
• RBBP8/CtIP suppresses P21 expression by interacting with CtBP and BRCA1 in gastric cancer

  2019cites this paper
• Genetic variation and radiation quality impact cancer promoting cellular phenotypes in response to HZE exposure.

  2019cites this paper
• Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

  2019cites this paper
• Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation

  2019cites this paper
• The Effects of Ludartin on Cell Proliferation, Cell Migration, Cell Cycle Arrest and Apoptosis Are Associated with Upregulation of p21WAF1 in Saos-2 Osteosarcoma Cells In Vitro

  2018cites this paper
• Breast cancer susceptibility protein 1 (BRCA1) rescues neurons from cerebral ischemia/reperfusion injury through NRF2-mediated antioxidant pathway

  2018cites this paper
• BRCA1 gene: function and deficiency

  2018cites this paper
• Functional Evaluation of ZNF350 Missense Genetic Variants Associated with Breast Cancer Susceptibility

  2018cites this paper
• Knockdown of GA-binding protein subunit β1 inhibits cell proliferation via p21 induction in renal cell carcinoma.

  2018cites this paper
• CtIP promotes G2/M arrest in etoposide‐treated HCT116 cells in a p53‐independent manner

  2018cites this paper
• Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance

  2018cites this paper
• THE IMPACT OF HISTAMINE RECEPTOR 2 ANTAGONISTS ON BREAST CANCER DEVELOPMENT AND MONOCYTIC POPULATIONS

  2018cites this paper
• BRCA1 Testing—Advances and Retreats

  2017cites this paper
• SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1

  2017cites this paper
• Structural basis to characterise transactivation domain of BRCA1

  2017cites this paper
• Involvement of miR-106b in tumorigenic actions of both prolactin and estradiol

  2017influential citation
• Prolactin inhibits a major tumor-suppressive function of wild type BRCA1.

  2016cites this paper
• Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• The Effect of Endothelin-1 on the expression of CDK Inhibitors p 21 & p 27 in Bovine Corneal Endothelial Cells

  2016cites this paper
• Hydroxylated-graphene quantum dots induce cells senescence in both p53-dependent and -independent manner.

  2016cites this paper
• Role of the Cell Cycle Re-Initiation in DNA Damage Response of Post-Mitotic Cells and Its Implication in the Pathogenesis of Neurodegenerative Diseases

  2016cites this paper
• The identification of novel strategies for the prevention and treatment of breast cancer in BRCA1-mutation carriers

  2016cites this paper
• Implications of BRCA1 mutations in basal-like breast cancer development and treatment

  2015cites this paper
• BRCA1 functions as a novel transcriptional cofactor in HIV-1 infection

  2015influential citation
• ResearchActivated networking of platelet activating factor receptor and FAK / STAT 1 induces malignant potential in BRCA 1-mutant at-risk ovarian epithelium

  2015cites this paper
• Identifying long-range control elements of the BRCA1 promoter

  2015cites this paper
• Oxidative stress response and Nrf2 signaling in aging.

  2015cites this paper
• ROLE OF BRCA1 AND BRCA2 GENES IN CELLULAR METABOLISM AND BREAST CANCER

  2015cites this paper
• BRCA1 regulates transforming growth factor‐β (TGF‐β1) signaling through Gadd45a by enhancing the protein stability of Smad4

  2015cites this paper
• TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

  2015cites this paper
• Host Cell Reactivation and Transcriptional Activation of Carboplatin-Modified BRCA1

  2014cites this paper
• Cooperation between BRCA1 and vitamin D is critical for histone acetylation of the p21waf1 promoter and for growth inhibition of breast cancer cells and cancer stem-like cells

  2014cites this paper
• Breast Cancer: Basic and Clinical Research

  2014cites this paper
• Novel Approaches to Studying BRCA Variants of Unknown Clinical Significance

  2014cites this paper
• A comparison of the gene expression profiles and pathway network analyses after treatment of Prostate cancer cell lines with different Ganoderma lucidum based extracts.

  2014cites this paper
• The expression of p21 is upregulated by forkhead box A1/2 in p53‐null H1299 cells

  2014cites this paper
• BRCA1 and Oxidative Stress

  2014cites this paper
• Cooperation between BRCA 1 and vitamin D is critical for histone acetylation of the p 21 waf 1 promoter and for growth inhibition of breast cancer cells and cancer stem-like cells

  2014cites this paper
• HP1 promotes tumor suppressor BRCA1 functions during the DNA damage response

  2013cites this paper
• Transgenic expression of BRCA1 disturbs hematopoietic stem and progenitor cells quiescence and function.

  2013cites this paper
• The Role of ERK5 in Cell Proliferation

  2013cites this paper
• FOXP3 rs2294021 Polymorphism Towards the Susceptibility To Breast Carcinoma In North Indian Population

  2013cites this paper
• Molecular Oncology in Gynecologic Cancer

  2013cites this paper
• Validation of a Gene-Expression Based Assay for BRCA1 Function

  2013cites this paper
• CtIP is required for DNA damage-dependent induction of P21

  2013cites this paper
• Synthetic glycopolypeptides as biomimetic analogues of natural glycoproteins.

  2013cites this paper
• Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation

  2013cites this paper
• Physiological modulation of endogenous BRCA1 p220 abundance suppresses DNA damage during the cell cycle

  2013cites this paper
• p21WAF1 and tumourigenesis: 20 years after

  2013cites this paper
• HP 1 promotes tumor suppressor BRCA 1 functions during the DNA damage response

  2013cites this paper
• BRCA1 mutations and luminal-basal transformation

  2013cites this paper
• Telomerase and its reverse transcriptase subunit TERT : identification and oestrogenic modulation of telomerase transcription in two aquatic test species - European Purple Sea Urchin (Paracentrotus Lividus) and Rainbow Trout (Oncorhynchus Mykiss)

  2012cites this paper
• Cancer Clinical Trials Optimization and Pharmacogenomics

  2012cites this paper
• BRCA 1 and MicroRNAs : Emerging Networks and Potential Therapeutic Targets

  2012cites this paper
• The role of FOXP3 in the development and metastatic spread of breast cancer

  2012cites this paper
• Clinical Trials in Cancer and Pharmacogenomics: A Critical Evaluation

  2012cites this paper
• Étude génomique du positionnement des nucléosomes contenant le variant d'histone H2A.Z dans des cellules humaines

  2012cites this paper
• Progress in research on correlation among STAT3, CyclinD1, P21 genes and tumors

  2012cites this paper
• Generation of Tanapoxvirus Ankyrin Repeat Gene Deletion Mutant for Evaluating its Role in Cell Tropism

  2012cites this paper
• Optimization and Pharmacogenomics

  2012cites this paper
• Análise da modulação androgênica na proliferação celular e expressão de genes alvo em hiperplasia prostática benigna e câncer de próstata

  2012cites this paper
• Heat shock protein 90 is a promising target for effective growth inhibition of gastrointestinal neuroendocrine tumors.

  2012cites this paper
• A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer

  2012cites this paper
• Establishment of Hey-triple-KO-ES cells and characterisation of Bre, a Hey binding partner

  2012cites this paper
• Xanthohumol Induces Different Cytotoxicity and Apoptotic Pathways in Malignant and Normal Astrocytes

  2012cites this paper
• Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells.

  2012cites this paper
• BRCA1 and MicroRNAs: Emerging networks and potential therapeutic targets

  2012cites this paper
• Insights into the targeted elimination of BRCA1‐defective cancer stem cells

  2012cites this paper
• Biosynthesis of Protein‐Based Polymeric Materials

  2011cites this paper